Net Sales Margin: Codexis, Inc. (CDXS)

Corporate emblem and logo of Codexis (CDXS)

Codexis, Inc. (CDXS) is in its maturity stage, scaling its pharmaceutical segment through bioengineering. The net profit margin demonstrates financial stability, with the latest value recorded as -21.80. Growth in key metrics is driven by the implementation of CodeEvolver AI platforms to automate DNA synthesis, as well as the creation of unique proteins that optimize chemical plant costs and accelerate drug release.

Codexis Inc (CDXS) - Net Return on Sales from 07/04/2022 to 11/19/2026

Summary analytical data breakdowns for codexis.com (CDXS)

- share price and consensus valuation forecast:
- company stock exchange capitalization indicators:
Summary company analysis:Codexis, Inc.
Manufactured product of Codexis, Inc.

Investors expect high returns from biocatalysis leader Codexis, Inc. (CDXS) through the implementation of CodeEvolver technology, which optimizes drug synthesis costs for the B2B sector. Quarterly profit margins reflect the portion of net income in every dollar of revenue, allowing for an assessment of cost control efficiency and the business's actual ability to convert technological superiority into a final financial result.

Key competitors

TEM: Net Sales Margin|Net Profitability Margin Qiagen QGEN|IONS (Isis Pharmaceuticals) - Net Sales Margin|Repligen Inc. - Net Profit Margin|Net Sales Margin RNA|CRSP - Net Margin|GeneDx - Return on Sales by Net Profit|Net Profit Rate RARE|Beam Tx - Net Sales Margin|SRPT - Net Sales Margin|TWST (Twist Bio) - Return on Sales by Net Profit|Net Return on Sales TXG|Return on Sales by Net Profit NTLA|Stoke Therapeutics Inc (STOK) - Company Sales Margin|Net Sales Margin BLFS|Net Margin WVE (Wave Life Sciences Corp)|Net Margin Maze Therapeutics MAZE|Net Profit Rate SION|PRME - Net Margin|Company Sales Margin Taysha TSHA|QURE: Net Sales Margin|Return on Sales by Net Profit MeiraGTx PLC|RGNX (REGENXBIO Inc) - Net Sales Margin|solidbio.com (SLDB) - Company Sales Margin|Net Margin Ocugen Corp (OCGN)|Pacific Biosciences of California, Inc. - Net Return on Sales|Benitec Biopharma - Return on Sales by Net Profit|DSGN: Net Return on Sales|RCKT: Return on Sales by Net Profit|FDMT - Net Sales Margin|LXEO: Net Sales Margin|Korro Bio Inc. - Net Profit Rate|EDIT (editasmedicine.com) - Net Sales Margin|Net Margin SLN|Net Margin ProQR Therapeutics NV (PRQR)|Net Sales Margin sangamo.com (SGMO)|Net Margin nautilus.bio NAUT|Company Sales Margin Metagenomi, Inc (MGX)|Precision BioSciences Inc. - Net Sales Margin|GBIO - Net Sales Margin|BOLD: Net Sales Margin|Net Return on Sales XCUR|Net Margin Imunon|Phio Pharmaceuticals - Net Profit Margin|Net Margin Mustang Bio, Inc. (MBIO)|Company Sales Margin TransCode Therapeutics, Inc.|Net Margin Bionano Genomics BNGO|Net Profit Rate APDN|BLUE - Net Margin|Net Profit Margin IPA|Omega Therapeutics, Inc. (OMGA) - Net Margin|Singular Genomics Corp (OMIC) - Net Sales Margin|RGLS (Regulus Therapeutics, Inc.) - Net Sales Margin|SYRS: Net Profit Rate|Return on Sales by Net Profit TBIO (Telesis Bio Inc.)|Net Sales Margin TRACON Pharmaceuticals Inc. (TCON)|Net Margin Unity Bio UBX